KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Net Cash Flow (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Net Cash Flow for 17 consecutive years, with $134.0 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 98.52% to $134.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.3 million through Dec 2025, down 22.18% year-over-year, with the annual reading at $59.3 million for FY2025, 22.18% down from the prior year.
  • Net Cash Flow for Q4 2025 was $134.0 million at Bio-Rad Laboratories, up from $25.4 million in the prior quarter.
  • The five-year high for Net Cash Flow was $324.7 million in Q1 2022, with the low at -$391.9 million in Q4 2021.
  • Average Net Cash Flow over 5 years is -$5.9 million, with a median of $21.7 million recorded in 2021.
  • The sharpest move saw Net Cash Flow soared 10341.97% in 2021, then tumbled 471.37% in 2022.
  • Over 5 years, Net Cash Flow stood at -$391.9 million in 2021, then skyrocketed by 83.27% to -$65.5 million in 2022, then rose by 27.71% to -$47.4 million in 2023, then skyrocketed by 242.45% to $67.5 million in 2024, then soared by 98.52% to $134.0 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $134.0 million, $25.4 million, and -$135.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.